Trials / Completed
CompletedNCT03894956
Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa
Special Drug Use-Results Survey of Evaluating Safety and Effectiveness of Humira in Long Term Treatment in Patients With Hidradenitis Suppurativa
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 0 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.
Conditions
Timeline
- Start date
- 2019-05-02
- Primary completion
- 2021-11-10
- Completion
- 2021-11-10
- First posted
- 2019-03-29
- Last updated
- 2022-11-03
Locations
37 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03894956. Inclusion in this directory is not an endorsement.